Clinical trial
Phase I/IIa Study on Chitin Microparticles in Subjects Suffering From Allergic…
NCT00443495 · CMP Therapeutics Ltd, Industry · Completed
Key facts
| NCT number | NCT00443495 |
|---|---|
| Title | Phase I/IIa Study on Chitin Microparticles in Subjects Suffering From Allergic Rhinitis |
| Official title | First Into Man Administration of Chitin Microparticles: a Randomised,Double Blind,Placebo Controlled Parallel Group Upward Titration Evaluation of 3 Dose Levels Given Intr-Nasally Over 24 Hours,Followed by a Placebo Controlled,Randomised Parallel Group Evaluation of Safety and Biological Activity… |
| Lead sponsor | CMP Therapeutics Ltd, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Seasonal Allergic Rhinitis |
| Intervention type | Drug |
| Interventions | Chitin microparticles by nasal route |
| Enrollment | 24 |
| Start date | Oct 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Mar 6, 2007 |
| Last update posted | Mar 6, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: